According to FutureWise analysis the biosimulation market in 2025 is US$ 4.73 billion and is expected to reach US$ 14.38 billion by 2033 at a CAGR of 14.91. This growth is fueled by the rising use of biosimulation in drug discovery and development to cut costs and speed up timelines. The integration of AI and predictive modeling is improving simulation accuracy in pharmacokinetics,...